Cargando…
Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells
Background: Breast cancer cells with tumor-initiating capabilities (BSCs) are considered to maintain tumor growth and govern metastasis. Hence, targeting BSCs will be crucial to achieve successful treatment of breast cancer. Methods: We characterized mammospheres derived from more than 40 cancer pat...
Autores principales: | Ma, Ran, Karthik, Govindasamy-Muralidharan, Lövrot, John, Haglund, Felix, Rosin, Gustaf, Katchy, Anne, Zhang, Xiaonan, Viberg, Lisa, Frisell, Jan, Williams, Cecilia, Linder, Stig, Fredriksson, Irma, Hartman, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441302/ https://www.ncbi.nlm.nih.gov/pubmed/28376210 http://dx.doi.org/10.1093/jnci/djw236 |
Ejemplares similares
-
Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling
por: Karthik, Govindasamy-Muralidharan, et al.
Publicado: (2017) -
Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers
por: Rantalainen, Mattias, et al.
Publicado: (2016) -
Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo
por: Klevebring, Daniel, et al.
Publicado: (2014) -
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
por: Katchy, Anne, et al.
Publicado: (2014) -
Oestrogen receptors β1 and βcx have divergent roles in breast cancer survival and lymph node metastasis
por: Rosin, G, et al.
Publicado: (2014)